By Carl O’Donnell An estimated 30 million to 50 million doses of Johnson & Johnson’s COVID-19 vaccine made early this year sits idle in Emergent BioSolutions Inc’s plant in Baltimore…
By Michael Erman NEW YORK – The U.S. Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and…
By Nancy Lapid The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to…
By Deena Beasley A late-stage trial of Biogen Inc’s experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its main goal, but secondary measures and…
By Julie Steenhuysen and Michael Erman Outside advisers to the U.S. Food and Drug Administration on Friday unanimously recommended the agency authorize a second shot of Johnson & Johnson’s COVID-19…
Pfizer says its COVID-19 vaccine works for children ages 5 to 11. The vaccine maker said Monday, Sept. 20, it plans to seek authorization for this age group soon in…
By Michael Erman and Julie Steenhuysen Scientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency’s criteria to support…
By Dan Levine and Marisa Taylor A recently recalled batch of Glucagon Emergency Kits, Eli Lilly and Co’s therapy for diabetic patients in crisis, was manufactured at an Indiana factory…
